Epoetin alfa in low hematocrit patients to facilitate autologous blood donation in total hip replacement: A randomized, double-blind, placebo-controlled, dose-ranging study

Acta Haematologica

Volumn 100, Issue 2, 1998, Pages 69-76

  Mercuriali, F ^a   Inghilleri, G ^a   Biffi, E ^a   Colotti, M T ^a   Vinci, A ^a   Oriani, G ^b  

^a ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

Author keywords

Anemia; Autologous blood donation; Autologous blood donation, perioperative; Epoetin alfa; Erythropoiesis; Orthopedic surgery

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; ASTHENIA; BLOOD DONOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HEMATOCRIT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; PAIN; PHLEBOTOMY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOTAL HIP PROSTHESIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD TRANSFUSION, AUTOLOGOUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EPOETIN ALFA; ERYTHROCYTE COUNT; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HUMANS; MALE; MIDDLE AGED; PLACEBOS; PREMEDICATION; TREATMENT OUTCOME;

EID: 0031759984     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040868     Document Type: Article

References (36)

1. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ: The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685-1690.
2. Walker RH: Special report: Transfusion risks. Am J Clin Pathol 1987;88:374-378.
3. Brzica SM: Complications of transfusion. Int Anesthesiol Clin 1982;20:171-193.
4. Dodd RY: The risk of transfusion-transmitted infection. N Engl J Med 1992;327:419-421.
5. Mezrow CK, Bergstein I, Tartter PI: Postoperative infections following autologous and homologous blood transfusions. Transfusion 1992;32:27-30.
6. Triulzi DJ, Vanek K, Ryan DH, Blumberg N: A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion 1992;32: 517-524.
7. Spence RK, Cernaianu AC, Carson J, DelRossi AJ: Transfusion and surgery. Curr Probl Surg 1993;30:1101-1180.
8. Council on Scientific Affairs : Autologous blood transfusions. JAMA 1986;256:2378-2380.
9. Goodnough LT, Shafron D, Marcus RE: The impact of preoperative autologous blood donation on orthopaedic surgical practice. Vox Sang 1990;59:65-69.
10. Woolson ST, Watt JM: Use of autologous blood in total hip replacement. A comprehensive program. J Bone Joint Surg Am 1991;73: 76-80.
11. Goodnough LT, Vizmeg K, Sobecks R, Schwarz A, Soegiarso W: Prevalence and classification of anemia in elective orthopedic surgery patients: Implications for blood conservation programs. Vox Sang 1992;63:90-95.
12. Goodnough LT, Wasman J, Corlucci K, Chernosky A: Limitations to donating adequate autologous blood prior to elective orthopedic surgery. Arch Surg 1989;124:494-496.
13. Kickler TS, Spivak JL: Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors. JAMA 1988;260:65-67.
14. Goodnough LT, Brittenham GM: Limitations of the erythropoietic response to serial phlebotomy: Implications for autologous blood donor programs. J Lab Clin Med 1990;115:28-35.
15. Cazenave J, Irrmann C, Waller C, Sondag D, Baudoux E, Genetet B, Laxenaire M, Dupont E, Sundal E, Obrist R, Stocker H: Epoetin alfa facilitates presurgical autologous blood donation in non-anaemic patients scheduled for orthopaedic or cardiovascular surgery. Eur J Anaesthesiol 1997;14:432-442.
16. Cazenave J, Sondag D, Genetet B: Recombinant human erythropoietin in non-anemic patients scheduled for orthopedic or cardiovascular surgery to facilitate perisurgical autologous blood donation. Br J Anaesth 1995;74:64.
17. Tryba M: Epoetin alfa plus autologous blood donation in patients with a low hematocrit scheduled to undergo orthopedic surgery. Semin Hematol 1996;33:22-26.
18. de Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M, Young DC: Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop 1996;25:533-542.
19. Faris PM, Ritter MA, Abels RI, American Prythropoietin Study Group: The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopedic operation. J Bone Joint Surg Am 1996;78:62-72.
20. Price T, Goodnough LT, Vogler W, Sacher RA, Hellman RM, Johnston MF, Bolgiano DC, Abels RI: The effect of recombinant human erythropoietin (epoetin alfa) administration on allogeneic blood use during orthopaedic surgery. Br J Anaesth 1995;74:64.
21. Mercuriali F, Gualtieri G, Sinigaglia L, Inghilleri G, Biffi E, Vinci A, Colotti MT, Barosi G, Lambertengh Deliliers G: Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery. Transfusion 1994;34:501-506.
22. Canadian Orthopedic Perioperative Erythropoietin Study Group: Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 1993;341: 1227-1232.
23. Mercuriali F, Zanella A, Barosi G, Inghilleri G, Biffi E, Vinci A, Colotti MT: Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993;33:55-60.
24. Adamson JW: The relationship of erythropoietin and iron metabolism to red blood cell production in humans. Semin Oncol 1994;21:9-15.
25. Cook JD: Clinical evaluation of iron deficiency. Semin Hematol 1982;19:6-18.
26. Cook JD, Skikne BS, Lynch SR, Reusser ME: Estimates of iron sufficiency in the US population. Blood 1986;68:726-731.
27. Gordeuk VR, Brittenham GM, Bravo J, Hughes MA, Keating LJ: Prevention of iron deficiency with carbonyl iron in female blood donors. Transfusion 1990;30:239-245.
28. Toy PT, Kaplan EB, McVay PA, Lee SJ, Strauss RG, Stehling LC: Blood loss and replacement in total hip arthroplasty: A multicenter study. The Preoperative Autologous Blood Donation Study Group. Transfusion 1992;32:63-67.
29. Price TH, Goodnough LT, Vogler WR, Sacher RA, Hellman RM, Johnston MF, Bolgiano DC, Abels RI: The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: A multicenter, randomized, double-blind, controlled trial. Transfusion 1996;36:29-36.
30. Goodnough LT, Rudnick S, Price TH, Ballas SK, Collins ML, Crowley JP, Kosmin M, Kruskall MS, Lenes BA, Menitove JE, Silberstein LE, Smith KJ, Wallas CH, Abels RI, Von Tress M: Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 1989;321:1163-1168.
31. Cohen JA, Brecher ME: Preoperative autologous blood donation: Benefit or detriment? A mathematical analysis. Transfusion 1995;35: 640-644.
32. Rutherford CJ, Schneider TJ, Dempsey H, Kirn DH, Brugnara C, Goldberg MA: Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: The importance of iron availability in optimizing response. Am J Med 1994;96: 139-145.
33. Biesma DH, Van de Wiel A, Beguin Y, Kraaijenhagen RJ, Marx JJ: Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy. Eur J Clin Invest 1994;24:426-432.
34. Cazzola M, Mercuriali F, Brugnara C: Use of recombinant human erythropoietin outside the setting of uremia. Blood 1997;89:4248-4267.
35. Brugnara C, Chambers LA, Malynn E, Goldberg MA, Kruskall MS: Red blood cell regeneration induced by subcutaneous recombinant erythropoietin: Iron-deficient erythropoiesis in iron-replete subjects. Blood 1993;81:956-964.
36. Goldberg MA, McCutchen JW, Jove M, Di Cesare P, Friedman RJ, Poss R, Guilfoyle M, Frei D, Young DC: A safety and efficacy comparison study of two dosing regimens of Epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 1996;25:544-552.